 | Up a level |
Dreger, Peter, Michallet, Mauricette, Bosman, Paul, Dietrich, Sascha, Sobh, Mohamad, Boumendil, Ariane, Nagler, Arnon, Scheid, Christof, Cornelissen, Jan, Niederwieser, Dietger, Mueller, Lutz, Vandenberghe, Elizabeth, Scortechini, Ilaria, Schoemans, Helene, Andersen, Niels S., Finke, Juergen, Russo, Domenico, Ljungman, Per, Passweg, Jakob, van Gelder, Michel, Durakovic, Nadira, Labussiere-Wallet, Helene, Berg, Tobias 
ORCID: 0000-0003-2668-0449, Wulf, Gerald, Bethge, Wolfgang, Bunjes, Donald, Stilgenbauer, Stefan, Canepari, Maria Elisa, Schaap, Michel, Fox, Christopher P., Kroeger, Nicolaus, Montoto, Silvia and Schetelig, Johannes
(2019).
Ibrutinib for bridging to allogeneic hematopoietic cell transplantation in patients with chronic lymphocytic leukemia or mantle cell lymphoma: a study by the EBMT Chronic Malignancies and Lymphoma Working Parties.
Bone Marrow Transplant., 54 (1).
S. 44 - 53.
LONDON:
NATURE PUBLISHING GROUP.
ISSN 1476-5365
Michallet, Mauricette, Dreger, Peter, Sobh, Mohamad, Koster, Linda, Hoek, Jennifer, Boumendil, Ariane ORCID: 0000-0002-2552-0542, Scheid, Christof, Fox, Christopher P., Wulf, Gerald, Krueger, William, van Gelder, Michel, Corradini, Paolo, Russo, Domenico, Passweg, Jakob, Schoemans, Helene, Bethge, Wolfgang, Schaap, Nicolaas, Cornelissen, Jan, Browne, Paul ORCID: 0000-0001-5310-1487, Durakovic, Nadira, Muller, Lutz, Montoto, Silvia, Kroger, Nicolaus and Schetelig, Johannes
(2020).
Ibrutinib as a salvage therapy after allogeneic HCT for chronic lymphocytic leukemia.
Bone Marrow Transplant., 55 (5).
S. 884 - 891.
LONDON:
SPRINGERNATURE.
ISSN 1476-5365